Moreover, in tumors with the following immunoprofile: S100+, SOX10-, SMA+ (diffuse reactivity) and the possibility of SMT should be taken into consideration and the confirmation of this diagnosis by expression of smooth muscle tumor markers is required. Here, SOX10 is linked to smooth muscle tumor.